Following on its initial description, BCL2 was discovered to function as an inhibitor of apoptosis, representing the first example of an oncogene that contributes to cancer by blocking cell death rather than promoting proliferation11 (Fig. 1c). The gene discussed is BCL2; the disease is cancer.